CUPRI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 179
AS - Asia 110
EU - Europa 72
AF - Africa 23
SA - Sud America 18
OC - Oceania 1
Totale 403
Nazione #
US - Stati Uniti d'America 174
SG - Singapore 53
IT - Italia 36
CN - Cina 35
BR - Brasile 17
CI - Costa d'Avorio 15
IE - Irlanda 12
KR - Corea 10
UA - Ucraina 7
DE - Germania 6
IN - India 6
SN - Senegal 6
CA - Canada 4
NL - Olanda 3
BD - Bangladesh 2
FI - Finlandia 2
SE - Svezia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
FR - Francia 1
GB - Regno Unito 1
GL - Groenlandia 1
PK - Pakistan 1
PL - Polonia 1
SA - Arabia Saudita 1
SC - Seychelles 1
TH - Thailandia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 403
Città #
Santa Clara 45
Singapore 43
Chicago 20
Chandler 18
Abidjan 15
Civitanova Marche 12
Dublin 12
Hefei 11
Seoul 10
Ashburn 8
Boardman 7
Jacksonville 7
Beijing 6
Catania 6
Dakar 6
Florence 4
Kochi 4
Los Angeles 4
Andover 3
Cambridge 3
Lawrence 3
São Paulo 3
Wilmington 3
Brooklyn 2
Columbus 2
Council Bluffs 2
Des Moines 2
Hanover 2
Munich 2
Ottawa 2
Stockholm 2
The Dalles 2
Toronto 2
Amsterdam 1
Annapolis 1
Bagnolo Cremasco 1
Bremen 1
Buffalo 1
Campina Grande 1
Campo Grande 1
Caruaru 1
Changsha 1
Chennai 1
Chongqing 1
Dalian 1
Dallas 1
Descalvado 1
Dhaka 1
Divinópolis 1
Dubai 1
Falls Church 1
Genoa 1
Giardini-Naxos 1
Grafing 1
Hebei 1
Hlukhiv 1
Ibiá 1
Itaberaba 1
Juiz de Fora 1
Lahore 1
Langfang 1
Lappeenranta 1
Manchester 1
Messina 1
Miami 1
Monmouth Junction 1
Monte Mor 1
Nanjing 1
Ningbo 1
Nuuk 1
Palermo 1
Porteirinha 1
Porto Alegre 1
Pretoria 1
Providence 1
Pune 1
Redmond 1
Redwood City 1
Ribeirão Preto 1
Ribeirão das Neves 1
Riyadh 1
San Francisco 1
San Mateo 1
Shenyang 1
Suffolk 1
Sydney 1
Turku 1
Valencia 1
Valparaíso de Goiás 1
Warsaw 1
Washington 1
Wichita Falls 1
Totale 332
Nome #
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 100
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 83
Long-Term Molecular Remission Achieved by Antibody Anti-CD22 and Ponatinib in a Patient Affected by Ph'+ Acute Lymphoblastic Leukemia Relapsed after Second Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report 74
Leishmania Infection during Ruxolitinib Treatment: The Cytokines-Based Immune Response in the Setting of Immunocompromised Patients 53
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 45
Transient Leukemoid Reaction from T-Cell Large Granular Lymphocytes Post Autologous Stem Cell Transplant in a Patient Affected by Hodgkin Lymphoma 33
Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease 31
Totale 419
Categoria #
all - tutte 1.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 1 1 2 6 2 6 0 3 0 1 1
2021/202222 2 3 0 0 4 2 3 0 1 0 2 5
2022/202362 3 7 0 5 4 5 1 19 10 1 7 0
2023/202455 0 9 1 4 5 13 3 3 0 4 10 3
2024/2025189 2 32 10 20 32 24 7 8 7 14 19 14
2025/202645 30 15 0 0 0 0 0 0 0 0 0 0
Totale 419